| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Training > Taking Part In A Trade Show? Then Ban Your CEO! |
|
Useful Advices - Taking Part In A Trade Show? Then Ban Your CEO!
Let me illustrate my point with a true story…. To set the scene, imagine the Main Hall at a successf According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ul Trade Show. There is that hum in the air that signifies lots of visitors talking business with lots of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in stallholders. At a Trade Show everyone knows everyone else. They’re all in the same market and many lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. re friends of long standing. Our culprit is the CEO of one of the bigger players in the industry. Le here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ’s call him Dave. Dave’s company had built a large opulent stand and business was brisk. Dave had a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ar built into his stand and rented a couple of plush leather Chesterfields, for him to entertain his gues ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s in style and comfort. On the last day of the show Dave was feeling particularly gregarious, helped easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi along no doubt, by the large amount of single malt he’d consumed. He was holding court in front of some nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically f the most esteemed figures in the industry and telling a long tale involving animated and exaggerated ar and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ movements. At this point alcohol overwhelmed his sense of balanced and he began a slow 45 degree si ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eways lurch across the stand and the neighboring walkway (still clutching his Scotch). His fall was ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lmost arrested by a vertical glass display case on a rivals stand opposite. The case slowly toppled backw dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rds with Dave almost astride it. In direct line with his flight path was an Octonorm pillar, which collap cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ed under the onslaught. The pillar supported the ceiling grid, onto which the lighting was fixed and the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen whole lot came down on top of Dave and a number of people on the stand. After the crash the hall fel t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel silent. The first sound was Dave letting forth an explosive profanity that seemed to echo around the Hal ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust . Then the cheering started…. The Moral Of The Story At Trade Shows people behave differently t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products they do at work. They tend to be more relaxed and off guard. If you were able to get Colonel Saunders to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de give you his recipe… it would be at a Trade Show. So if your CEO is like Dave (and many are) you mus elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip find a way of keeping him quiet, both for the sake of your Company’s reputation and your neighbors stand tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Postcards - Picture Perfect Promotion
|